The purpose of the present study was to investigate the levels of FABP1 and FABP2 in T2DM patients in various stages of nephropathy to clarify the role of FABP1 and FABP2 in the pathogenesis of diabetic nephropathy. This evidence concerns the gene FABP2 and diabetic kidney disease.